July 22, 2015 — The Medicines Company announced the U.S. Court of Appeals for the Federal Circuit Court has ruled ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
July 22, 2015
July 21, 2015 "” Two companion papers published in Academic Emergency Medicine address the question of when it is ...
July 21, 2015
July 13, 2015 - Researchers have created tiny gel particles that can perform the same essential functions as platelets ...
July 13, 2015
July 7, 2015 - Results from an interim analysis of the Phase III RE-VERSE AD patient study demonstrate that 5 g of ...
July 07, 2015
July 1, 2015 - The American College of Cardiology (ACC) Statin Intolerance App is now available to help guide clinicians ...
July 01, 2015
June 22, 2015 - The Medicines Company announced the approval of cangrelor (Kengreal) by the U.S. Food and Drug ...
June 22, 2015
June 18, 2015 - Atrial fibrillation patients on the anticoagulant dabigatran were more likely to adhere to the ...
June 18, 2015
June 17, 2015 - Merck announced that the New England Journal of Medicine published the results of the IMPROVE-IT trial ...
June 17, 2015June 11, 2015 - Patients who received a bare metal coronary stent did not display significant differences in rates of ...
June 11, 2015
June 9, 2015 - AstraZeneca announced full results from the PEGASUS-TIMI 54 study, a large-scale outcomes trial ...
June 10, 2015June 4, 2015 - Researchers from the University of Chicago and Stanford University combed through scientific literature ...
June 04, 2015
May 21, 2015 — Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from the ...
May 21, 2015
May 18, 2015 — A risk assessment algorithm combining clinical risk factors and platelet function test results may help ...
May 18, 2015
May 18, 2015 — Patients with a high-risk paclitaxel drug-eluting stent given the shorter-acting antiplatelet drug cilost ...
May 18, 2015
May 15, 2015 — Prasugrel (Effient) is more likely to be given to lower-risk heart disease patients undergoing percutaneo ...
May 15, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now